Literature DB >> 12370817

Identification of Src transformation fingerprint in human colon cancer.

Renae L Malek1, Rosalyn B Irby, Qingbin M Guo, Kerry Lee, Sylvia Wong, Mei He, Jennifer Tsai, Bryan Frank, Edison T Liu, John Quackenbush, Richard Jove, Timothy J Yeatman, Norman H Lee.   

Abstract

We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell undergoes when progressing from a normal to a transformed phenotype. Src activation is evident in 80% of human colon cancer, yet the myriad of cellular processes effected at the level of gene expression has yet to be fully documented. We identified a Src 'transformation fingerprint' within the gene expression profiles of Src-transformed rat 3Y1 fibroblasts demonstrating a progression in transformation characteristics. To evaluate the role of this gene set in human cancer development and progression, we extracted the orthologous genes present on the Affymetrix Hu95A GeneChip (12k named genes) and compared expression profiles between the Src-induced rodent cell line model of transformation and staged colon tumors where Src is known to be activated. A similar gene expression pattern between the cell line model and staged colon tumors for components of the cell cycle, cytoskeletal associated proteins, transcription factors and lysosomal proteins suggests the need for co-regulation of several cellular processes in the progression of cancer. Genes not previously implicated in tumorigenesis were detected, as well as a set of 14 novel, highly conserved genes with here-to-fore unknown function. These studies define a set of transformation associated genes whose up-regulation has implications for understanding Src mediated transformation and strengthens the role of Src in the development and progression of human colon cancer. Supportive Supplemental Data can be viewed at http://pga.tigr.org/PGApubs.shtml.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370817     DOI: 10.1038/sj.onc.1205900

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity.

Authors:  Nikki Gillum Posnack; Norman H Lee; Ronald Brown; Narine Sarvazyan
Journal:  Toxicology       Date:  2010-10-08       Impact factor: 4.221

2.  Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Authors:  Ze-Ya Pan; Yun Yang; Hao Pan; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Lei Yin; Jian Huang; Wei-Ping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution.

Authors:  Laila Illán Rubio; Bertrand Tavitian; Elina Zueva
Journal:  Clin Exp Metastasis       Date:  2009-11-11       Impact factor: 5.150

4.  Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer.

Authors:  John J Arcaroli; Basel M Touban; Aik Choon Tan; Marileila Varella-Garcia; Rebecca W Powell; S Gail Eckhardt; Paul Elvin; Dexiang Gao; Wells A Messersmith
Journal:  Clin Cancer Res       Date:  2010-08-03       Impact factor: 12.531

5.  DNA methylation in lung tissues of mouse offspring exposed in utero to polycyclic aromatic hydrocarbons.

Authors:  Trevor J Fish; Abby D Benninghoff
Journal:  Food Chem Toxicol       Date:  2017-05-02       Impact factor: 6.023

6.  Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion.

Authors:  Carrie D House; Charles J Vaske; Arnold M Schwartz; Vincent Obias; Bryan Frank; Truong Luu; Narine Sarvazyan; Rosalyn Irby; Robert L Strausberg; Tim G Hales; Joshua M Stuart; Norman H Lee
Journal:  Cancer Res       Date:  2010-07-22       Impact factor: 12.701

7.  Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Authors:  Yoshiki Mukudai; Seiji Kondo; Atsushi Fujita; Yasuto Yoshihama; Tatsuo Shirota; Satoru Shintani
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

8.  Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.

Authors:  Bart M Maślikowski; Benjamin D Néel; Ying Wu; Lizhen Wang; Natalie A Rodrigues; Germain Gillet; Pierre-André Bédard
Journal:  BMC Cancer       Date:  2010-02-12       Impact factor: 4.430

9.  Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine.

Authors:  Jenica D Tapocik; Noah Letwin; Cheryl L Mayo; Bryan Frank; Troung Luu; Ovokeraye Achinike; Carrie House; Russell Williams; Greg I Elmer; Norman H Lee
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

Review 10.  Src kinases as therapeutic targets for cancer.

Authors:  Lori C Kim; Lanxi Song; Eric B Haura
Journal:  Nat Rev Clin Oncol       Date:  2009-10       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.